Clinical trials: Phase 1 First-in-human Study Involving Healthy Subjects
Phase 1 First-in-human Study Involving Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects
- Trial name
- NCT07473752
- Testing
- TNX-1500, Keyhole Limpet Hemocyanin (KLH)
- Where
- United States
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Tonix Pharmaceuticals, Inc.